4th Quarter - Report
THE MCMANUS GROUP for ANTIMICROBIAL INNOVATION ALLIANCE
Firm
Income
$80,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
H.R.2029 - Consolidated Appropriations Act, 2016.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| CHASE M THOMAS | — |
| BARRETT THORNHILL | — |
Health Issues HCR
Development of policies to advance the antimicrobial research and development environment; including advancing new market incentives. Support of H.R. 512 - DISARM Act of 2015 language in H.R. 6 - The 21st Century Cures Act. Antibiotic policy regarding Innovation for Healthier Americans Report.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| CHASE M THOMAS | — |
| BARRETT THORNHILL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.